Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 12, 2010, Pages 1953-1957

  Rehni, Ashish Kumar ^a   Singh, Thakur Gurjeet ^a   Behl, Nidhi ^a   Arora, Sandeep ^a  

^a CHITKARA UNIVERSITY   (India)

Author keywords

Cerebral injury; Ischemic preconditioning; Protease; Ubiquitin proteasome system; Z leu leu phe chinese hamster ovary

Indexed keywords

PROTEINASE; TRIPHENYLTETRAZOLIUM; UBIQUITIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME MECHANISM; FEMALE; ISCHEMIC PRECONDITIONING; MALE; MAZE TEST; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; REPERFUSION INJURY; ROTAROD TEST; SHORT COURSE THERAPY; SPATIAL MEMORY; THERAPY DELAY; THERAPY EFFECT;

ANIMALS; ATAXIA; BRAIN; CAROTID ARTERIES; CEREBRAL INFARCTION; CRICETINAE; CRICETULUS; FEMALE; ISCHEMIC PRECONDITIONING; MALE; MEMORY DISORDERS; MICE; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; REPERFUSION INJURY; UBIQUITIN;

EID: 78751525954     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1953     Document Type: Article

References (45)

1. Baker K., Markus C. B., Huffman K., Kruk H., Malfory B., Doctrow S. R., J. Pharmacol. Exp. Ther., 284, 215-221 (1998).
2. Whisnant J. H., Stroke, 15, 160-168 (1984).
3. Murray C. E., Jennings R. B., Reimer K. A., Circulation, 74, 1124-1136 (1986).
4. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., Brain Res., 528, 21-24 (1990).
5. Banerjee A., Locke W. C., Rogers K. B., Mitchell M. B., Brew E. C., Cairns C. B., Bensard D. D., Harken A. H., Circ. Res., 73, 656-670 (1993).
6. Yao Z., Gross G. J., Am. J. Physiol., 264, H2221-H2225 (1993a).
7. Yao Z., Gross G. J., Circ. Res., 73, 1193-1201 (1993b).
8. Goto M., Liu Y., Yang X. M., Ardell J. L., Cohen M. V., Downey J. M., Circ. Res., 77, 611-621 (1995).
9. Liu Y., Tsuchida A., Cohen M. V., Downey J. M., J. Mol. Cell. Cardiol., 27, 883-892 (1995).
10. Mullane K., Bullough D., J. Mol. Cell. Cardiol., 27, 1041-1054 (1995).
11. Erikson J. M., Velasco C. E., Am. Heart J., 132, 84-90 (1996).
12. Schultz J. E., Hsu A. K., Gross G. J., Circ. Res., 78, 1100-1104 (1996).
13. Verma R., Deshaies R. J., Cell, 101, 341-344 (2000).
14. Herrmann J., Lerman L. O., Lerman A., Circ. Res., 100, 1276-1291 (2007).
15. Meller R., Cameron J. A., Torrey D. J., Clayton C. E., Ordonez A. N., Henshall D. C., Minami M., Schindler C. K., Saugstad J. A., Simon R. P., J. Biol. Chem., 281, 7429-7436 (2006).
16. Meller R., Thompson S. J., Lusardi T. A., Ordonez A. N., Ashley M. D., Jessick V., Wang W., Torrey D. J., Henshall D. C., Gafken P. R., Saugstad J. A., Xiong Z. G., Simon R. P., J. Neurosci., 28, 50-59 (2008).
17. Benardete E. A., Bergold P. J., Brain Res., 1292, 107-122 (2009).
18. Powell S. R., Divald A., Cardiovasc. Res., 85, 303-311 (2010).
19. Schauer S. L., J. Immunol., 160, 4398 (1998).
20. Ferrara A., Bejaoui S. E., Seyen S., Tirelli E., Plumier J. C., Behav. Brain Res., 205, 525-534 (2009).
21. Jenkins L. W., Povlishock J. T., Lewelt W., Miller J. D., Becker D. P., Acta Neuropathologica, 5, 205-220 (1981).
22. Neumar R. W., Ann. Emerg. Med., 36, 483-506 (2000).
23. Dobkin B. H., Clin. Geriatric Med., 7, 507-523 (1991).
24. Yamamoto Y., Shioda N., Han F., Moriguchi S., Nakajima A., Yokosuka A., Mimaki Y., Sashida Y., Yamakuni T., Ohizumi Y., Fukunaga K., Brain Res., 1295, 218-229 (2009).
25. Rehni A. K., Bhateja P., Singh N., Jaggi A. S., Fundam. Clin. Pharmacol., 22, 179-188 (2008a).
26. Rehni A. K., Singh T. G., Jaggi A. S., Singh N., Pharmacol. Rep., 60, 904-913 (2008b).
27. Rehni A. K., Bhateja P., Singh N., Can. J. Physiol. Pharmacol., 87, 63-68 (2009).
28. Rehni A. K., Singh T. G., Bhateja P., Singh N., Arora S., Brain Res., 1309, 75-82 (2010).
29. Himori N., Wantanabe H., Akaike N., Kurasawa M., Itoh J., Tanaka Y., J. Pharmacol. Methods, 23, 311-327 (1990).
30. Bochelen D., Rudin M., Sauter A., J. Pharmacol. Exp. Ther., 288, 653-659 (1999).
31. Itoh J., Nabeshima T., Kameyama T., Psychopharmacology, 101, 27-32 (1990).
32. Dunham N. W., Miya T. S., J. Am. Pharm. Assoc. Am. Pharm. Assoc. (Baltimore), 46, 208-209 (1957).
33. Yi J. J., Ehlers M. D., Pharmacol. Rev., 591, 14-39 (2007).
34. Wojcik C., Di Napoli M., Stroke, 35, 1506-1518 (2004).
35. Stangl K., Stangl V., Cardiovasc. Res., 85, 281-290 (2010).
36. Singh B. N., Rao K. S., Rao Ch. M., Biochim. Biophys. Acta, 1803, 288-299 (2010).
37. Ashida H., Kim M., Schmidt-Supprian M., Ma A., Ogawa M., Sasakawa C., Nat. Cell Biol., 12, 66-73 (2010).
38. Lee J., Choi K., Choi C., Biochem. Biophys. Res. Commun., 391, 33- 37 (2010).
39. Shibata T., Imaizumi T., Tamo W., Matsumiya T., Kumagai M., Cui X. F., Yoshida H., Takaya S., Fukuda I., Satoh K., Immunol. Cell Biol., 80, 226-230 (2002).
40. Yan D., Guo L., Wang Y., J. Cell. Biol., 174, 415-424 (2006).
41. Guo Z. H., Li F., Wang W. Z., Neurosci. Bull., 25, 139-152 (2009).
42. Breitschopf K., Haendeler J., Malchow P., Zeiher A. M., Dimmeler S., Mol. Cell. Biol., 20, 1886-1896 (2000).
43. Lopez Verrilli M. A., Pirola C. J., Pascual M. M., Dominici F. P., Turyn D., Gironacci M. M., J. Neurochem., 109, 326-335 (2009).
44. Chaturvedi K., Christoffers K. H., Singh K., Howells R. D., Biopolymers, 55, 334-346 (2000).
45. Sun F., Kanthasamy A., Song C., Yang Y., Anantharam V., Kanthasamy A. G., J. Cell. Mol. Med., 12, 2467-2481 (2008).